At‐Home Versus in‐Clinic Vital Capacity Measurement: Insights From the HEALEY ALS Platform Trial
Eric A Macklin, James D Berry, Brittney A Harkey, Lindsay Heyd, Marianne Chase, Hong Yu, Alexander V Sherman, Derek Dagostino, Gale Kittle, Meghan Hall, Mariah R Connolly, Kristin Drake, Elisa Giacomelli, Erica Scirocco, Saloni Sharma, Suma Babu, Michael Benatar, Zachary Simmons, Eufrosina Young, Merit E Cudkowicz, Jeremy Shefner, Sabrina Paganoni, the HEALEY ALS Platform Trial Study Group · 2026
Read At‐Home Versus in‐Clinic Vital Capacity Measurement: Insights From the HEALEY ALS Platform Trial by Eric A Macklin, James D Berry, Brittney A Harkey, Lindsay Heyd, Marianne Chase, Hong Yu, Alexander V Sherman, Derek Dagostino, Gale Kittle, Meghan Hall, Mariah R Connolly, Kristin Drake, Elisa Giacomelli, Erica Scirocco, Saloni Sharma, Suma Babu, Michael Benatar, Zachary Simmons, Eufrosina Young, Merit E Cudkowicz, Jeremy Shefner, Sabrina Paganoni, the HEALEY ALS Platform Trial Study Group (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13471965.txt.
Description
Eric A Macklin leads the HEALEY ALS Platform Trial group in 2026 comparing breathing capacity measured at home against the clinic standard in amyotrophic lateral sclerosis. Breathing strength guides trial eligibility and tracks decline in this fatal motor neuron disease. Home measurements, coached live by video and reviewed centrally, were paired with clinic readings taken within two weeks, across 233 participants followed for a year.
The two settings agreed well, with no systematic bias in either direction. A home reading above the trial threshold predicted a passing clinic reading nine times in ten, though a failing home reading was less decisive. Decline slopes correlated moderately, with home readings falling somewhat faster but varying less between people. Both slopes predicted survival time similarly. The authors back home measurement for future trials.
Catalog record
| CREATOR | Eric A Macklin, James D Berry, Brittney A Harkey, Lindsay Heyd, Marianne Chase, Hong Yu, Alexander V Sherman, Derek Dagostino, Gale Kittle, Meghan Hall, Mariah R Connolly, Kristin Drake, Elisa Giacomelli, Erica Scirocco, Saloni Sharma, Suma Babu, Michael Benatar, Zachary Simmons, Eufrosina Young, Merit E Cudkowicz, Jeremy Shefner, Sabrina Paganoni, the HEALEY ALS Platform Trial Study Group |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 30727 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |